Podcasts by ARD podcast
Annals of the Rheumatic Diseases (ARD) is an international peer-reviewed journal committed to promoting the highest standards of scientific exchange and education. It covers all aspects of rheumatology, which includes the spectrum of musculoskeletal conditions, arthritic disease, and connective tissue disorders. ARD publishes basic, clinical, and translational scientific research. Concise scientific communication is encouraged and peer-reviewed proceedings of international meetings are featured. ARD is the official journal of EULAR.
* The purpose of this podcast is to educate and to inform. The content of this podcast does not constitute medical advice and it is not intended to function as a substitute for a healthcare practitioner’s judgement, patient care or treatment. The views expressed by contributors are those of the speakers. BMJ does not endorse any views or recommendations discussed or expressed on this podcast. Listeners should also be aware that professionals in the field may have different opinions. By listening to this podcast, listeners agree not to use its content as the basis for their own medical treatment or for the medical treatment of others.
Further podcasts by BMJ Group
Podcast on the topic Wissenschaft
All episodes
Innate Lymphoid Cells link TGFb and fibrotic pathways in systemic sclerosis skin from 2022-02-07T21:50:06
In this podcast, Dr. Truchetet discusses her work on the role of innate lymphoid cells in the fibrotic processes in systemic sclerosis (SSc) patients. The group of Dr. Truchetet found that ILC2 are...
ListenImmunogenicity of anti-SARS-CoV-2 mRNA vaccines in patients with rheumatic diseases from 2021-07-29T17:01:10
In this podcast, we invite two authors from recent ARD papers dedicated to the efficacy of mRNA vaccines in patients with immunosuppressive therapies. Christophe Richez, Department of Rheumatology...
ListenThe EULAR COVID-19 database and its insights into risk factors from 2021-03-18T16:35:01
The EULAR COVID-19 database and the COVID-19 Global Rheumatology Alliance work together on shared collected data to address the most pertinent questions in regard to risks for people with rheumatic...
ListenPredictors of disease worsening in systemic sclerosis from 2020-09-15T10:21:12
Capturing disease progression in SSc is challenging. Becker and colleagues addressed this problem by identifying predictors of disease worsening in the EUSTAR cohort. ARD's social media advisor Dr....
ListenTreating Cytokine Storm Syndrome in COVID-19 patients with glucocorticoids and tocilizumab from 2020-08-06T16:38:43
In this podcast, Dr. Paul Studenic speaks to Dr. Sofia Ramiro and Prof. Robert Landewé both engaged in clinical work in the Zuyderland Medical Center in the south of the Netherlands about their cli...
ListenThe dose dependent effect of statins on osteoporosis from 2020-04-22T09:08:25
Statins are some of the most commonly prescribed cholesterol-lowering drugs. They act by inhibiting HMG-CoA reductase, the main enzyme in the synthesis of cholesterol. Earlier studies have shown th...
ListenA prediction score for individuals at risk to develop rheumatoid arthritis from 2020-03-25T17:34:28
In this podcast recorded at the ACR meeting 2019, Dr. Caroline Ospelt speaks to Prof. Anca Catrina and Dr. Aase Hensvold both of the Division of Rheumatology at the Department of Medicine located a...
ListenPrediction of radiographic progression using synovitis characteristics from 2020-03-06T11:58:16
Dr. Felice Rivellese from the Center of Experimental Medicine and Rheumatology at the Queen Mary University in London discusses the results of his presentation at the ACR 2019 with Dr. Caroline ...
ListenSix-week treatment with low-dose prednisolone in patients with painful hand osteoarthritis from 2020-02-18T16:54:42
This randomised, double-blind, placebo-controlled trial by Kroon et al has demonstrated a substantial improvement in painful hand OA with signs of inflammation following six weeks of low-dose pr...
ListenHighlights from ACR: guselkumab, ixekizumab and secukinumab in SpA from 2020-01-23T17:06:02
Atul Deodhar, from the Oregon Health&Science University, provides an overview of recent clinical trial results in the area of seronegative Spondylarthritis. He presented the 24-week data of Guse...
ListenTULIP 2: Efficacy and Safety of Anifrolumab in Patients from 2019-12-23T15:32:08
TULIP 2: Efficacy and Safety of Anifrolumab in Patients with Moderate to Severe Systemic Lupus Erythematosus: Results of the Second Phase 3 Randomized Controlled Trial.
In this second phase 3 tri...
ListenTULIP 1 - highlights from the ACR meeting from 2019-12-10T10:43:01
TULIP 1: A Phase 3 Randomized Controlled Trial of Anifrolumab in Patients with Moderate to Severe Systemic Lupus Erythematosus
In this first phase 3 trial, the primary endpoint, SRI(4), was not a...
ListenCapture Hi-C reveals novel drug targets in rheumatic diseases from 2019-08-22T15:44:29
The paper discussed in this podcast provides an approach, using Capture Hi-C data, to link genetic associations to potential causal genes and assess the potential of drug repurposing in three rheum...
ListenEULAR recommendations for the management of systemic lupus erythematosus from 2019-07-12T15:09:14
The highlights of the latest update of the EULAR recommendations for the management of systemic lupus erythematosus (SLE), based on emerging new evidence, are discussed in this podcast.
Read the ...
ListenMusculoskeletal diseases on the rise worldwide and affecting developed countries the most from 2019-06-03T13:52:02
Musculoskeletal diseases have increased significantly between 2000 and 2015 and are now the second cause of years lived with disability worldwide, a study recently published by ARD concludes. The p...
ListenThree tips to get your manuscript published by ARD from 2018-08-29T14:31:43
Find out how to increase your chances of a successful submission in this very short podcast with Annals of the Rheumatic Diseases’s Associate Editor Francis Berenbaum. He is interviewed by the Soci...
ListenEarly inflammatory arthritis outcomes: what changed in the new millennium? from 2018-07-10T16:07:17
A study that compares the 10-year outcome (disease activity, disability, mortality) of two cohorts of patients with inflammatory polyarthritis recruited 10 years apart is discussed in this podcast....
ListenSimilar performance of Humira and BI695501 biosimilar in active rheumatoid arthritis from 2018-03-28T19:18:42
The switch from Humira to BI 695501 had no impact on efficacy, safety and immunogenicity in patients with moderately to severely active rheumatoid arthritis, according to a study recently published...
ListenPatient and doctor discordance may reduce chances of remission in rheumatoid and psoriatic arthritis from 2018-01-31T22:38:54
Discordance between patient's and physician's evaluation of disease activity may reduce likelihood of remission in rheumatoid arthritis and psoriatic arthritis. Dr Paul Studenic, Austria, is joine...
ListenLupus and Hughes syndrome: EULAR recommendations for women's health and family planning from 2017-04-20T11:52:37
What are the recommendations of The European League Against Rheumatism (EULAR) for women's health and family planning after a diagnosis of lupus and/or antiphospholipid syndrome, also known as Hugh...
ListenInflammatory arthritis and sicca syndrome induced by cancer treatment from 2016-12-06T18:03:38
Welcome to the first Annals of the Rheumatic Diseases (ARD) podcast. In this conversation, Marie Kostine (France) and Laura Cappelli (Johns Hopkins University, Baltimore, USA) discuss onco andimmun...
ListenJohannes Bijlsma from 2014-07-03T10:24:34
Johannes Bijlsma is an Associate Editor on ARD and in this podcast he explains his role in the journal. He also talks through the EULAR textbook and online course in his capacity as education of...
Listen